Unveiling 6 Analyst Insights On Treace Medical Concepts
Unveiling 6 Analyst Insights On Treace Medical Concepts
公佈分析師對Treace醫療概念的6點見解
Analysts' ratings for Treace Medical Concepts (NASDAQ:TMCI) over the last quarter vary from bullish to bearish, as provided by 6 analysts.
6位分析師提供的分析師對Treace Medical Concepts(納斯達克股票代碼:TMCI)在上個季度的評級從看漲到看跌不等。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
下表彙總了他們最近的評級,闡明瞭過去30天內情緒的變化,並將其與前幾個月進行了比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $8.17, a high estimate of $16.00, and a low estimate of $5.50. A negative shift in sentiment is evident as analysts have decreased the average price target by 48.39%.
分析師分析的12個月目標股價提供了見解,平均目標價爲8.17美元,最高估計爲16.00美元,低估值爲5.50美元。隨着分析師將平均目標股價下調了48.39%,情緒的負面轉變顯而易見。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析師評級:全面細分
A comprehensive examination of how financial experts perceive Treace Medical...
對金融專家如何看待T...
登入免費觀看全文
登入/註冊